Christopher Morris

Other News

Press Release

New Phase 3 Study Shows that Gazyva® (obinutuzumab) Significantly Reduces Lupus Disease Activity in SLE

March 6, 2026
A new Phase 3 study published in the New England Journal of Medicine found that Gazyva® (obinutuzumab) significantly reduced disease activity...
Press Release

Lupus Research Alliance Applauds U.S. FDA Fast Track Designation for Nipocalimab for Systemic Lupus Erythematosus 

March 4, 2026
Decision Could Help Potential SLE Treatment Reach People Living With Lupus Sooner Decision Could Help Potential SLE Treatment...
Press Release

Lupus Therapeutics, the Clinical Affiliate of the Lupus Research Alliance, Broadens Proven Peer-to-Peer Program in Clinical Trials

February 24, 2026
New Centralized Model to Include Hundreds of Research Sites Across North America Today, Lupus Therapeutics, the clinical affiliate of the...